A genome-wide scan for urinary albumin excretion in hypertensive families

Hypertension

Volumn 42, Issue 3, 2003, Pages 291-296

  Freedman, Barry I ^a   Beck, Stephanie R ^a   Rich, Stephen S ^a   Heiss, Gerardo ^b   Lewis, Cora E ^c   Turner, Stephen ^d   Province, Michael A ^e   Schwander, Karen L ^e   Arnett, Donna K ^f   Mellen, Beverly G ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b IL   (United States)

^c University of Alabama at Birmingham   (United States)

^d MAYO CLINIC   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Albuminuria; Blacks; Hypertension, essential; Nephrosclerosis; Race

Indexed keywords

ALBUMIN; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGE; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CHROMOSOME 12; CHROMOSOME 19; DIABETES MELLITUS; FAMILY; FEMALE; GENDER; GENETIC LINKAGE; GENOME; GENOTYPE; HERITABILITY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NEPHROSCLEROSIS; PRIORITY JOURNAL; PROTEINURIA; RACE;

ADULT; AGED; ALBUMINURIA; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 19; FAMILY HEALTH; FEMALE; GENOME, HUMAN; HUMANS; HYPERTENSION; LOD SCORE; MALE; MIDDLE AGED;

EID: 10744227968     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000087890.33245.41     Document Type: Article

References (25)

1. Fogarty DG, Hanna LS, Wantman M, Warram JH, Krolewski AS, Rich SS. Segregation analysis of urinary albumin excretion in families with type 2 diabetes. Diabetes. 2000;49:1057-1063.
2. Imperatore G, Knowler WC, Pettitt DJ, Kobes S, Bennett PH, Hanson RL. Segregation analysis of diabetic nephropathy in Pima Indians. Diabetes. 2000;49:1049-1056.
3. Freedman BI. End-stage renal failure in African Americans: insights in kidney disease susceptibility. Nephrol Dial Transplant. 2002;17:198-200.
4. Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR, UKPDS GROUP. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int. 2002;63:225-232.
5. Garg JP, Bakris GL. Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease. Vasc Med. 2002;7:35-43.
6. Gerstein HC, Mann JF, Pogue J, Dinneen SF, Halle JP, Hoogwerf B, Joyce C, Rashkow A, Young J, Zinman B, Yusuf S. Prevalence and determinants of microalbuminuria in high-risk diabetic and nondiabetic patients in the Heart Outcomes Prevention Evaluation Study. Diabetes Care. 2000;23(suppl 2):B35-B39.
7. Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289:2560-2572.
8. Brown DM, Provoost AP Daly MJ, Lander ES, Jacob HJ. Renal disease susceptibility and hypertension are under independent genetic control in the fawn-hooded rat. Nat Genet. 1996;12:44-51.
9. Schulz A, Litfin A, Kossmehl P, Kreutz R. Genetic dissection of increased urinary albumin excretion in the Munich Wistar Frömter rat. J Am Soc Nephrol. 2002;13:2706-2714.
10. Garrett MR, Dene H, Rapp JP. Time-course genetic analysis of albuminuria in Dahl salt-sensitive rats on low-salt diet. J Am Soc Nephrol. 2003;14:1175-1187.
11. DeWan AT, Arnett DK, Atwood LD, Province MA, Lewis CE, Hunt SC, Eckfeldt J. A genome scan for renal function among hypertensives: the HyperGEN study. Am J Hum Genet. 2001;68:136-144.
12. DeWan AT, Arnett DK, Miller MB, Peacock JM, Atwood LD, Province MA, Lewis CE, Hunt SC, Eckfeldt JH. Refined mapping of suggestive linkage to renal function in African Americans: the HyperGEN study. Am J Hum Genet. 2002;71:204-205.
13. Williams RR, Rao DC, Ellison RC, Arnett DK, Heiss G, Oberman A, Eckfeldt JH, Leppert MF, Province MA, Mockrin SC, Hunt SC. NHLBI family blood pressure program: methodology and recruitment in the HyperGen network. Ann Epidemiol. 2000;10:389-400.
14. Kruglyak L, Lander ES. High-resolution genetic mapping of complex traits. Am J Hum Genet. 1995;56:1212-1223.
15. O'Connell JR, Weeks DE. PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet. 1998;63:259-266.
16. McPeek MS, Sun L. Statistical tests for detection of misspecified relationships by use of genome-screen data. Am J Hum Genet. 2000;66:1076-1094.
17. Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet. 1998;62:1198-1211.
18. Goldgar DE. Multipoint analysis of human quantitative genetic variation. Am J Hum Genet. 1990;47:957-967.
19. Amos CI. Robust variance-components approach for assessing genetic linkage in pedigrees. Am J Hum Genet. 1994;54:535-543.
20. Blangero J, Williams JT, Almasy L. Robust LOD scores for variance component-based linkage analysis. Genet Epidemiol. 2000;19(suppl 1):S8-S14.
21. Perkins BA, Ficociello LH, Silva KH, Finkelstein DM, Warram JH, Krolewski AS. Regression of microalbuminuria in type I diabetes. N Engl J Med. 2003;348:2285-2293.
22. Nishina PM, Johnson JP, Naggert JK, Krauss RM. Linkage of atherogenic lipoprotein phenotype to the low density lipoprotein receptor locus on the short arm of chromosome 19. Proc Natl Acad Sci USA. 1992;89:708-712.
23. Rotter JI, Xiangdong B, Cantor RM, Warden CH, Brown J, Gray RJ, Blanche PJ, Krauss RM, Lusis AJ. Multilocus genetic determinants of LDL particle size in coronary artery disease families. Am J Human Genet. 1996;58:585-594.
24. Bianchi S, Bigazzi R, Caiazza A, Campese VM. A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of renal disease. Am J Kidney Dis. 2003;41:565-570.
25. Coon H, Leppert MF, Eckfeldt JH, Oberman A, Myers RH, Peacock JM, Province MA, Hopkins PN, Heiss G. Genome-wide linkage analysis of lipids in the Hypertension Genetic Epidemiology Network (HyperGEN) Blood Pressure Study. Arterioscler Thromb Vasc Biol. 2001;21:1969-1976.